These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7529222)

  • 21. [Clinical studies on the detection of hepatitis C virus genome in the serum and the liver].
    Hige S
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1382-98. PubMed ID: 7535730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose.
    Shiffman ML; Hofmann CM; Luketic VA; Sanyal AJ; Contos MJ; Mills AS
    Hepatology; 1996 Jul; 24(1):21-6. PubMed ID: 8707264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
    Tong MJ; Reddy KR; Lee WM; Pockros PJ; Hoefs JC; Keeffe EB; Hollinger FB; Hathcote EJ; White H; Foust RT; Jensen DM; Krawitt EL; Fromm H; Black M; Blatt LM; Klein M; Lubina J
    Hepatology; 1997 Sep; 26(3):747-54. PubMed ID: 9303508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C and G co-infection: response to interferon therapy and quantitative changes in serum HGV-RNA.
    McHutchison JG; Nainan OV; Alter MJ; Sedghi-Vaziri A; Detmer J; Collins M; Kolberg J
    Hepatology; 1997 Nov; 26(5):1322-7. PubMed ID: 9362379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon and ursodeoxycholic acid combined therapy in the treatment of chronic viral C hepatitis: results from a controlled randomized trial in 80 patients.
    Boucher E; Jouanolle H; Andre P; Ruffault A; Guyader D; Moirand R; Turlin B; Jacquelinet C; Brissot P; Deugnier Y
    Hepatology; 1995 Feb; 21(2):322-7. PubMed ID: 7843700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of total dose of IFN in the treatment of chronic hepatitis C].
    Imazeki F; Yokosuka O
    Nihon Rinsho; 1994 Jul; 52(7):1794-7. PubMed ID: 7521420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Outcome of the cases of chronic liver disease type C who exhibited long term response to interferon therapy; comparison of the cases with or without serum HCV-RNA].
    Tohyama H; Iwabuchi S; Takatori M
    Nihon Shokakibyo Gakkai Zasshi; 1996 Nov; 93(11):813-20. PubMed ID: 8953921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
    Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
    Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus antibody titration in patients with chronic hepatitis C, before and after interferon treatment.
    Takahashi M; Yamada G; Miyamoto R; Doi T; Endo H; Nishimoto H; Fujiki S; Shimomura H; Mizuno M; Tsuji T
    Acta Med Okayama; 1992 Oct; 46(5):331-6. PubMed ID: 1279945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Histological assessment of the liver long after interferon treatment in patients with chronic type C hepatitis].
    Yokosuka O; Hosoda K; Omata M
    Nihon Rinsho; 1994 Jul; 52(7):1841-6. PubMed ID: 7521428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C.
    McGuinness PH; Bishop GA; Painter DM; Chan R; McCaughan GW
    Hepatology; 1996 Apr; 23(4):676-87. PubMed ID: 8666317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
    Martinot-Peignoux M; Marcellin P; Pouteau M; Castelnau C; Boyer N; Poliquin M; Degott C; Descombes I; Le Breton V; Milotova V
    Hepatology; 1995 Oct; 22(4 Pt 1):1050-6. PubMed ID: 7557850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy.
    Shiffman ML; Stewart CA; Hofmann CM; Contos MJ; Luketic VA; Sterling RK; Sanyal AJ
    J Infect Dis; 2000 Dec; 182(6):1595-601. PubMed ID: 11069229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.
    Zeuzem S; Schmidt JM; Lee JH; Rüster B; Roth WK
    Hepatology; 1996 Feb; 23(2):366-71. PubMed ID: 8591865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
    Bellobuono A; Mondazzi L; Tempini S; Silini E; Idéo G
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon therapy of hepatitis C. Who to treat and for how long?
    Van Thiel DH
    J Gastroenterol Hepatol; 1997 Jun; 12(6):450-2. PubMed ID: 9195403
    [No Abstract]   [Full Text] [Related]  

  • 37. Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA.
    Shiratori Y; Yokosuka O; Nakata R; Ihori M; Hirota K; Katamoto T; Unuma T; Okano K; Ikeda Y; Hirano M; Kawase T; Takano S; Matsumoto K; Ohashi Y; Omata M
    Hepatology; 1999 May; 29(5):1573-80. PubMed ID: 10216145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative evaluation of serum HCV RNA by Roche Monitor Assay. Versions 1.0 and 2.0; as a predictive marker of subsequent response to IFN therapy].
    Takenokuchi M; Yasuda C; Nakamachi Y; Mukai M; Yoon S; Kondoh S; Kumagai S
    Rinsho Byori; 2002 Apr; 50(4):392-7. PubMed ID: 12014019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.